RETA : Reata Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-31 |
|---|---|---|---|---|
| 2023 | $86.68 | $80.18 | $91.48 | -4.67% |
| 2024 | $65.54 | $58.11 | $77.53 | -27.91% |
| 2025 | $51.54 | $44.54 | $57.81 | -43.31% |
| 2026 | $42.25 | $41.14 | $43.21 | -53.53% |
| 2027 | $36.18 | $32.53 | $40.39 | -60.21% |
| 2028 | $30.28 | $29.1 | $32.1 | -66.7% |
| 2029 | $29.1 | $28.97 | $29.43 | -67.99% |
| 2030 | $31.66 | $29.58 | $35.53 | -65.18% |
| 2031 | $57.91 | $37.27 | $80.75 | -36.31% |
| 2032 | $85.21 | $80.78 | $87.94 | -6.28% |
| 2033 | $77.35 | $75.01 | $79.52 | -14.93% |
The 16 Wall Street analysts offering Reata Pharmaceuticals stock forecast in the last 6 months have average price target of
$96.19 with a high forecast of $185.0 and a low forecast of $50.0.
The average Reata Pharmaceuticals stock forecast represents a 5.8%
increase from the last price of $90.9199981689453.
From AI system, total return is 2366.52% from 4098 forecasts.
For Reata Pharmaceuticals stock forecast for 2023, 8 predictions are offered for each month of 2023 with average Reata Pharmaceuticals stock
forecast of $86.68, a high forecast of $91.48, and a low forecast of $80.18.
The average Reata Pharmaceuticals stock forecast 2023 represents a -4.67%
decrease from the last price of $90.9199981689453.
For Reata Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Reata Pharmaceuticals stock
forecast of $65.54, a high forecast of $77.53, and a low forecast of $58.11.
The average Reata Pharmaceuticals stock forecast 2024 represents a -27.91%
decrease from the last price of $90.9199981689453.
For Reata Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Reata Pharmaceuticals stock
forecast of $42.25, a high forecast of $43.21, and a low forecast of $41.14.
The average Reata Pharmaceuticals stock forecast 2026 represents a -53.53%
decrease from the last price of $90.9199981689453.
For Reata Pharmaceuticals stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Reata Pharmaceuticals stock
forecast of $30.28, a high forecast of $32.1, and a low forecast of $29.1.
The average Reata Pharmaceuticals stock forecast 2028 represents a -66.7%
decrease from the last price of $90.9199981689453.
For Reata Pharmaceuticals stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Reata Pharmaceuticals stock
forecast of $57.91, a high forecast of $80.75, and a low forecast of $37.27.
The average Reata Pharmaceuticals stock forecast 2031 represents a -36.31%
decrease from the last price of $90.9199981689453.
For Reata Pharmaceuticals stock forecast for 2033 (10 year), 4 predictions are offered for each month of 2033 with average Reata Pharmaceuticals stock
forecast of $77.35, a high forecast of $79.52, and a low forecast of $75.01.
The average Reata Pharmaceuticals stock forecast 2033 represents a -14.93%
decrease from the last price of $90.9199981689453.
Please, see more forecasts below.
RETA : Reata Pharmaceuticals stock forecast by Wall Street Analysts
The average Reata Pharmaceuticals stock forecast from last 6 month is $96.19, and this show a 36.94% increase in average from the prior price target of the each prediction. Also, this average forecast of $96.19 represents a 97.64% increase from the past average forecast of $48.67, 6 months ago from 3 wall street analysts.
Reata Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-04-03 | $90.80 | -0.13% |
| 2023-04-04 | $89.64 | -1.29% |
| 2023-04-05 | $89.44 | -0.22% |
| 2023-04-06 | $88.65 | -0.88% |
| 2023-04-07 | $87.82 | -0.94% |
RETA : Long term Reata Pharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 May. is $91.48 , for 2024 Apr. is $69.36 , for 2027 Apr. is $37.93 , for 2028 Apr. is $30.90 , for 2032 Apr. is $87.94 , and for 2033 Apr. is $75.01.
RETA : Reata Pharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 May. | $91.48 | 0.61% |
| 2023 Jun. | $90.82 | -0.72% |
| 2023 Jul. | $89.54 | -1.41% |
| 2023 Aug. | $87.99 | -1.73% |
| 2023 Sep. | $86.41 | -1.80% |
| 2023 Oct. | $84.53 | -2.17% |
| 2023 Nov. | $82.46 | -2.45% |
| 2023 Dec. | $80.18 | -2.77% |
RETA : Reata Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $77.53 | -3.30% |
| 2024 Feb. | $74.73 | -3.62% |
| 2024 Mar. | $71.93 | -3.74% |
| 2024 Apr. | $69.36 | -3.58% |
| 2024 May. | $67.07 | -3.29% |
| 2024 Jun. | $65.00 | -3.08% |
| 2024 Jul. | $63.14 | -2.86% |
| 2024 Aug. | $61.53 | -2.55% |
| 2024 Sep. | $60.26 | -2.07% |
| 2024 Oct. | $59.29 | -1.61% |
| 2024 Nov. | $58.56 | -1.23% |
| 2024 Dec. | $58.11 | -0.76% |
RETA : Reata Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $57.81 | -0.53% |
| 2025 Feb. | $57.55 | -0.44% |
| 2025 Mar. | $57.22 | -0.58% |
| 2025 Apr. | $55.72 | -2.62% |
| 2025 May. | $54.01 | -3.07% |
| 2025 Jun. | $52.27 | -3.22% |
| 2025 Jul. | $50.49 | -3.40% |
| 2025 Aug. | $48.92 | -3.12% |
| 2025 Sep. | $47.58 | -2.74% |
| 2025 Oct. | $46.64 | -1.96% |
| 2025 Nov. | $45.75 | -1.92% |
| 2025 Dec. | $44.54 | -2.64% |
RETA : Reata Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $43.21 | -2.98% |
| 2026 Feb. | $41.95 | -2.91% |
| 2026 Mar. | $41.31 | -1.54% |
| 2026 Apr. | $41.87 | 1.37% |
| 2026 May. | $42.36 | 1.16% |
| 2026 Jun. | $42.69 | 0.77% |
| 2026 Jul. | $42.87 | 0.43% |
| 2026 Aug. | $42.87 | 0.00% |
| 2026 Sep. | $42.66 | -0.49% |
| 2026 Oct. | $42.29 | -0.86% |
| 2026 Nov. | $41.79 | -1.20% |
| 2026 Dec. | $41.14 | -1.54% |
RETA : Reata Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $40.39 | -1.82% |
| 2027 Feb. | $39.58 | -2.01% |
| 2027 Mar. | $38.75 | -2.11% |
| 2027 Apr. | $37.93 | -2.11% |
| 2027 May. | $37.14 | -2.06% |
| 2027 Jun. | $36.39 | -2.03% |
| 2027 Jul. | $35.66 | -2.02% |
| 2027 Aug. | $34.94 | -2.01% |
| 2027 Sep. | $34.25 | -1.97% |
| 2027 Oct. | $33.60 | -1.88% |
| 2027 Nov. | $33.02 | -1.72% |
| 2027 Dec. | $32.53 | -1.51% |
RETA : Reata Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $32.10 | -1.31% |
| 2028 Feb. | $31.71 | -1.22% |
| 2028 Mar. | $31.30 | -1.27% |
| 2028 Apr. | $30.90 | -1.29% |
| 2028 May. | $30.52 | -1.22% |
| 2028 Jun. | $30.19 | -1.10% |
| 2028 Jul. | $29.90 | -0.95% |
| 2028 Aug. | $29.66 | -0.80% |
| 2028 Sep. | $29.46 | -0.66% |
| 2028 Oct. | $29.31 | -0.53% |
| 2028 Nov. | $29.19 | -0.41% |
| 2028 Dec. | $29.10 | -0.31% |
RETA : Reata Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $29.04 | -0.22% |
| 2029 Feb. | $29.00 | -0.14% |
| 2029 Mar. | $28.98 | -0.07% |
| 2029 Apr. | $28.97 | -0.01% |
| 2029 May. | $28.98 | 0.03% |
| 2029 Jun. | $29.00 | 0.08% |
| 2029 Jul. | $29.04 | 0.12% |
| 2029 Aug. | $29.08 | 0.16% |
| 2029 Sep. | $29.14 | 0.21% |
| 2029 Oct. | $29.22 | 0.26% |
| 2029 Nov. | $29.32 | 0.33% |
| 2029 Dec. | $29.43 | 0.40% |
RETA : Reata Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $29.58 | 0.50% |
| 2030 Feb. | $29.76 | 0.61% |
| 2030 Mar. | $29.98 | 0.73% |
| 2030 Apr. | $30.24 | 0.88% |
| 2030 May. | $30.56 | 1.05% |
| 2030 Jun. | $30.93 | 1.23% |
| 2030 Jul. | $31.38 | 1.43% |
| 2030 Aug. | $31.89 | 1.66% |
| 2030 Sep. | $32.51 | 1.94% |
| 2030 Oct. | $33.27 | 2.33% |
| 2030 Nov. | $34.24 | 2.92% |
| 2030 Dec. | $35.53 | 3.77% |
RETA : Reata Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $37.27 | 4.91% |
| 2031 Feb. | $39.61 | 6.25% |
| 2031 Mar. | $42.62 | 7.60% |
| 2031 Apr. | $46.30 | 8.65% |
| 2031 May. | $50.53 | 9.12% |
| 2031 Jun. | $55.06 | 8.97% |
| 2031 Jul. | $59.67 | 8.38% |
| 2031 Aug. | $64.24 | 7.65% |
| 2031 Sep. | $68.71 | 6.97% |
| 2031 Oct. | $73.04 | 6.29% |
| 2031 Nov. | $77.10 | 5.57% |
| 2031 Dec. | $80.75 | 4.74% |
RETA : Reata Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $83.80 | 3.77% |
| 2032 Feb. | $86.05 | 2.69% |
| 2032 Mar. | $87.40 | 1.57% |
| 2032 Apr. | $87.94 | 0.62% |
| 2032 May. | $87.84 | -0.11% |
| 2032 Jun. | $87.29 | -0.62% |
| 2032 Jul. | $86.45 | -0.97% |
| 2032 Aug. | $85.44 | -1.17% |
| 2032 Sep. | $84.34 | -1.29% |
| 2032 Oct. | $83.18 | -1.37% |
| 2032 Nov. | $82.00 | -1.43% |
| 2032 Dec. | $80.78 | -1.49% |
RETA : Reata Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $79.52 | -1.56% |
| 2033 Feb. | $78.17 | -1.69% |
| 2033 Mar. | $76.69 | -1.90% |
| 2033 Apr. | $75.01 | -2.18% |
Frequently Asked Questions about Reata Pharmaceuticals stock forecast
Is Reata Pharmaceuticals a good long term stock?
From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock can be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2023 May. is $91.4782497176554 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2024 Apr. is $69.3568726867117 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2027 Apr. is $37.927461543336 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2028 Apr. is $30.8984625000047 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2032 Apr. is $87.9408738021297 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2033 Apr. is $75.0131238155418
Is Reata Pharmaceuticals stock overvalued?
Reata Pharmaceuticals (RETA) stock is expected to go DOWN . Therefore, Tudal would say that Reata Pharmaceuticals (RETA) stock is overvalued.
Will Reata Pharmaceuticals stock price go up?
No. The Reata Pharmaceuticals stock price forecast for 2024 Apr. is $69.3568726867117
Is Reata Pharmaceuticals stock a good buy now?
Since closing price on 2023-03-31 is $90.9199981689453 and forecast for 2024 Apr. is $69.36, Reata Pharmaceuticals stock is not a good 1 year investment.